Wanjun Chen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Globe Newswire. The AP news staff was not involved in its creation. MATEON ANNOUNCES POSITIVE INTERIM RESULTS FROM ARTI-19 CLINICAL TRIAL EVALUATING COVID-19 ... Mateon Therapeutics, Inc.January 13, 2021 GMT AGOURA HILLS, California, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB: MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and COVID-19, reported positive interim results from its ARTI-19 clinical trial evaluating ARTIVedaTM against COVID-19. “These interim results suggest that ARTIVeda is a well-tolerated and...

MATEON ANNOUNCES POSITIVE INTERIM RESULTS FROM ARTI-19 CLINICAL TRIAL EVALUATING COVID-19 THERAPEUTIC Mateon Therapeutics, Inc. ARTI-19 CLINICAL TRIAL EVALUATING COVID-19 THERAPEUTIC AGOURA HILLS, California, Jan. 13, 2021 (GLOBE NEWSWIRE) — Mateon Therapeutics, Inc. (OTCQB: MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and COVID-19, reported positive interim results from its ARTI-19 clinical trial evaluating ARTIVeda TM against COVID-19. “These interim results suggest that ARTIVeda is a well-tolerated and effective treatment for COVID-19 that produces a f...